First-generation SARM (MK-2866/Enobosarm) with tissue-selective anabolic activity. Preserves and builds lean muscle mass while promoting fat oxidation. Originally developed for muscle wasting and osteoporosis. Mildest SARM with lowest suppression risk.
Take orally daily. Lowest suppression risk among SARMs — PCT optional at 10-15mg for 8 weeks. Blood work recommended.
Log doses, calculate reconstitution, set reminders, and get AI guidance for Ostarine Peptide Analog.
Start Free Trial